FindTrial
Sign In

Interval debulking surgery

PROCEDURE5 trials

Sponsors

Shanghai Gynecologic Oncology Group, Shu-Zhong Cui, The University of Hong Kong, Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions

Epithelial Ovarian CancerFallopian Tube CancerFallopian Tube CancersHigh-grade Serous Ovarian Cancer (HGSOC)Ovarian CancerPeritoneal CancerPrimary Peritoneal CancerPrimary Peritoneal Carcinoma

Phase 2

Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
RecruitingNCT07022535
The University of Hong KongFallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer
Start: 2024-05-28End: 2025-12-31Target: 18Updated: 2025-07-02
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
RecruitingNCT07023484
The University of Hong KongFallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma
Start: 2025-05-22End: 2028-12-31Target: 126Updated: 2025-07-02
Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer
Not yet recruitingNCT07432594
Cancer Institute and Hospital, Chinese Academy of Medical SciencesFallopian Tube Cancers, High-grade Serous Ovarian Cancer (HGSOC), Primary Peritoneal Cancer
Start: 2026-03-01End: 2027-06-30Target: 82Updated: 2026-02-25

Phase 3

Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)
Active, not recruitingNCT02859038
Shanghai Gynecologic Oncology GroupEpithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Start: 2016-08-31End: 2027-06-30Updated: 2025-02-10
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
NCT03180177
Shu-Zhong CuiEpithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Start: 2018-03-01End: 2022-07-01Target: 263Updated: 2018-01-24

Related Papers

Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept
Journal of Gynecologic Oncology2020-01-0141 citations